Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Markers Predict Response Rate and Prognosis After Temozolomide Treatment
Link ID 3427
Title Markers Predict Response Rate and Prognosis After Temozolomide Treatment
Url http://www.medscape.com/viewarticle/570434?src=rss
Description Researchers have identified a genetic marker that appears to predict chemosensitivity to temozolomide treatment and prognosis in gliomatosis cerebri brain tumors. Medscape Medical News
Category Articles > Hematology-Oncology
Keywords
Date Feb 21, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. Insurance Status Linked to Cancer Stage at Diagnosis
  Uninsured patients and those covered by Medicaid are far more likely to present with advanced-stage cancer at diagnosis than those with private coverage. Medscape Medical News
Category:   Articles > Hematology-Oncology


2. Routine MRI at Breast Cancer Diagnosis Linked to Treatment Delays
  Among women newly diagnosed with breast cancer, magnetic resonance imaging (MRI) evaluation does not clarify tumor margins or improve selection for breast conserving therapy (BCT), and it appears to delay treatment, researchers reported in Washington, DC, at the 2008 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium. Reuters Health Information
Category:   Articles > Hematology-Oncology


3. Gemcitabine-Based Combination Chemotherapy Ups Survival in Pancreatic Cancer
  Gemcitabine, in combination with platinum analogs or fluoropyrimidines, improves survival in patients with advanced pancreatic cancer, according to results of a meta-analysis reported in the March 28th issue of BMC Cancer. Reuters Health Information
Category:   Articles > Hematology-Oncology


4. Sirolimus Reduces Size of Angiomyolipoma Tumors
  The immunosuppressive drug sirolimus led to shrinkage of angiomyolipomata tumors in patients with tuberous sclerosis complex and/or lymphangioleiomyomatosis. Medscape Medical News
Category:   Articles > Hematology-Oncology


5. Adjuvant Therapy for HER2-Positive Breast Cancer: An Expert Interview With Dr. Harold Burstein
  What do clinicians need to know in 2008? Dr. Harold Burstein brings readers up to date about trastuzumab-based regimens, selecting a chemotherapy backbone, and monitoring cardiac function.
Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS